Guillermo de Velasco

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

Yasin Şenbabaoğlu, Ron S. Gejman, Andrew Winer et al. · Genome biology · 2016 · 1K citations · Full text

Medicine, Immunology, Oncology +17

A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations

Yiqun Zhang, Patrick Kwok‐Shing Ng, Melanie H. Kucherlapati et al. · Cancer Cell · 2017 · 656 citations

Life Sciences, Molecular Biology, Oncology +14

Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients

Guillermo de Velasco, Youjin Je, Dominick Bossé et al. · Cancer Immunology Research · 2017 · 476 citations · Full text

Medicine, Oncology, Pharmacology +17

Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma

Fengju Chen, Yiqun Zhang, Yasin Şenbabaoğlu et al. · Cell Reports · 2016 · 381 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

T. Powles, Laurence Albigès, Axel Bex et al. · Annals of Oncology · 2024 · 300 citations · Full text

Medicine, Nephrology, Oncology +14